BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8468919)

  • 1. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of platelet activating factor by human neutrophils after backfiltration of endotoxin contaminated dialysate.
    David S; Tetta C; Canino F; Gervasio R; Cambi V
    ASAIO J; 1993; 39(3):M773-7. PubMed ID: 8268642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
    Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
    Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
    Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I
    Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the dialysate fluid source of complement activating factors?
    Minetti L; Broggi ML; Civati G; Guastoni C; Teatini U
    Trans Am Soc Artif Intern Organs; 1985; 31():673-7. PubMed ID: 3879782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis.
    Gastaldello K; Husson C; Wens R; Vanherweghem JL; Tielemans C
    Nephrol Dial Transplant; 2000 Oct; 15(10):1638-46. PubMed ID: 11007834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
    Leong HS; Mahesh BM; Day JR; Smith JD; McCormack AD; Ghimire G; Podor TJ; Rose ML
    J Leukoc Biol; 2008 Feb; 83(2):263-71. PubMed ID: 17974709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species.
    Itoh S; Susuki C; Tsuji T
    J Biomed Mater Res A; 2006 May; 77(2):294-303. PubMed ID: 16400657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils.
    Chang SW
    Clin Res; 1992 Oct; 40(3):528-36. PubMed ID: 1395440
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain.
    Park TS; Gonzales ER; Gidday JM
    J Cereb Blood Flow Metab; 1999 Apr; 19(4):417-24. PubMed ID: 10197511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.
    Hörl WH
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S62-71. PubMed ID: 11792764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redistribution of P-selectin ligands on neutrophil cell membranes and the formation of platelet-neutrophil complex induced by hemodialysis membranes.
    Itoh S; Takeshita K; Susuki C; Shige-Eda K; Tsuji T
    Biomaterials; 2008 Jul; 29(21):3084-90. PubMed ID: 18452987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation.
    Walcher F; Marzi I; Fischer R; Bauer M; Larsen R
    J Surg Res; 1996 Feb; 61(1):244-9. PubMed ID: 8769973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.
    Bussolati B; Mariano F; Cignetti A; Guarini A; Cambi V; Foà R; Piccoli G; Camussi G
    J Immunol; 1998 Aug; 161(3):1493-500. PubMed ID: 9686616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.